Sanofi (EPA:SAN)
78.84
-0.67 (-0.84%)
Sep 16, 2025, 5:38 PM CET
Sanofi Revenue
Sanofi had revenue of 10.74B EUR in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 45.74B, up 15.65% year-over-year. In the year 2024, Sanofi had annual revenue of 44.29B with 7.73% growth.
Revenue (ttm)
45.74B
Revenue Growth
+15.65%
P/S Ratio
2.12
Revenue / Employee
551.87K
Employees
82,878
Market Cap
96.75B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 44.29B | 3.18B | 7.73% |
Dec 31, 2023 | 41.11B | 805.00M | 2.00% |
Dec 31, 2022 | 40.30B | 1.13B | 2.88% |
Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
Dec 31, 2020 | 37.37B | -262.00M | -0.70% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 27.24B |
Sartorius Stedim Biotech | 2.90B |
bioMérieux | 4.12B |
Eurofins Scientific SE | 7.14B |
Ipsen | 3.76B |
ABIVAX Société Anonyme | 6.02M |
Virbac | 1.43B |
emeis Société anonyme | 5.64B |
Sanofi News
- 1 day ago - How the UK fell out with big pharma - CNBC
- 4 days ago - Britain is ‘a terrible place’ to sell medicines, says drug firm executive - The Guardian
- 5 days ago - Press Release: Sanofi's SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration - Benzinga
- 5 days ago - Press Release: Sanofi's SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration - GlobeNewsWire
- 5 days ago - US tariffs, pricing risks to be manageable for Big Pharma, Morningstar says - Reuters
- 6 days ago - Mandy Moore and Celebrity Mom Squad join Sanofi to help protect babies from RSV with BEYFORTUS® - PRNewsWire
- 6 days ago - Sanofi (SNY) Gains China Approval for Groundbreaking Diabetes Drug - GuruFocus
- 6 days ago - Sanofi’s Tzield approved in China to delay type 1 diabetes progression - Seeking Alpha